Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue 10, 2015, Pages 1657-1663

  Sippel, Trisha R ^a   Shimizu, Takeru ^a   Strnad, Frank ^a   Traystman, Richard J ^a   Herson, Paco S ^a   Waziri, Allen ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Inova Neuroscience Institute   (United States)

Author keywords

basic science; brain ischemia; immunology; immunosuppression; leukocytes; T cells

Indexed keywords

ARGINASE 1; ARGININE; GAMMA INTERFERON; ARG1 PROTEIN, MOUSE; ARGINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEGRANULATION; ENZYME RELEASE; IMMUNE DEFICIENCY; INTERFERON PRODUCTION; LEUKOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CYTOLOGY; ENZYMOLOGY; IMMUNOLOGICAL TOLERANCE; MALE; METABOLISM; NEUTROPHIL; PARASITOLOGY; PATHOLOGY; SPLEEN; T LYMPHOCYTE;

ANIMALS; ARGINASE; ARGININE; IMMUNE TOLERANCE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; NEUTROPHILS; SPLEEN; STROKE; T-LYMPHOCYTES;

EID: 84942986468     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.103     Document Type: Article

References (25)

1. Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007; 38: 1097-1103.
2. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 2007; 252: 29-35.
3. Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, Torres F et al. Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 2006; 37: 461-465.
4. Vermeij FH, Scholte op Reimer WJ, De Man P, Van Oostenbrugge RJ, Franke CL, De Jong G et al. Stroke-Associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 2009; 27: 465-471.
5. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60: 620-625.
6. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007; 38: 770-773.
7. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006; 37: 2607-2612.
8. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736.
9. Vogelgesang A, Dressel A. Immunological consequences of ischemic stroke: immunosuppression and autoimmunity. J Neuroimmunol 2011; 231: 105-110.
10. Sippel TR, White J, Nag K, Tsvankin V, Klaassen M, Kleinschmidt-DeMasters BK et al. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clinical Cancer Res 2011; 17: 6992-7002.
11. Munder M. Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 2009; 158: 638-651.
12. Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E et al. Role of arginine metabolism in immunity and immunopathology. Immunobiology 2007; 212: 795-812.
13. Bronte V, Zanovello P. Regulation of immune responses by L-Arginine metabolism. Nat Rev Immunol 2005; 5: 641-654.
14. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
15. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM et al. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2005; 105: 2549-2556.
16. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clinical Cancer Res 2007; 13: 721s-726s.
17. Jia J, Verma S, Nakayama S, Quillinan N, Grafe MR, Hurn PD et al. Sex differences in neuroprotection provided by inhibition of TRPM2 channels following experimental stroke. J Cereb Blood Flow Metab 2011; 31: 2160-2168.
18. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 2011; 31: 8556-8563.
19. Siemsen DW, Schepetkin IA, Kirpotina LN, Lei B, Quinn MT. Neutrophil isolation from nonhuman species. Methods Mol Biol 2007; 412: 21-34.
20. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006; 176: 6523-6531.
21. Jacobsen LC, Theilgaard-Monch K, Christensen EI, Borregaard N. Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood 2007; 109: 3084-3087.
22. Munder M, Schneider H, Luckner C, Giese T, Langhans CD, Fuentes JM et al. Suppression of T-cell functions by human granulocyte arginase. Blood 2006; 108: 1627-1634.
23. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371: 1612-1623.
24. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-Analysis. Lancet 2012; 379: 2364-2372.
25. Harston GW, Sutherland BA, Kennedy J, Buchan AM. The contribution of L-Arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab 2010; 30: 1804-1816.